BiotechTubeBiotechTube
Home/Eterna Therapeutics/Matthew Angel
MA

Matthew Angel

Interim President and Chief Executive Officer

Eterna Therapeutics

Therapeutic Areas

Regenerative MedicineOncologyAutoimmune Disorders

Eterna Therapeutics Pipeline

DrugIndicationPhase
Hypoimmune Engineered CellsRegenerative Medicine (e.g., Type 1 Diabetes)Preclinical
mRNA-reprogrammed T CellsOncology (CAR-T/TCR-T therapies)Preclinical
In Vivo Cell ReprogrammingAutoimmune Disorders, Tissue RepairDiscovery

Leadership Team at Eterna Therapeutics

JL
Joshua Leonard
Chief Financial Officer
SL
Sanjeev Luther
Former President and Chief Executive Officer
View full Eterna Therapeutics profile